Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2012
09/13/2012WO2012122564A2 Diagnostic and sample preparation devices and methods
09/13/2012WO2012122533A2 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb
09/13/2012WO2012122525A1 Process controls for molecular assay
09/13/2012WO2012122477A1 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
09/13/2012WO2012122447A1 Methods of using microrna-26a to promote angiogenesis
09/13/2012WO2012122436A2 Molecular zipper tweezers and spring devices
09/13/2012WO2012122369A1 Novel bacillus thuringiensis gene with lepidopteran activity
09/13/2012WO2012122326A1 Engineered bacteria for oral delivery of glucoregulatory proteins
09/13/2012WO2012122320A2 Shape memory polymer intraocular lenses
09/13/2012WO2012122317A2 Apparatus and methods for bone repair preparation
09/13/2012WO2012122290A2 Citrus greening (huanglongbing)-induced small rnas are potential early diagnosis markers
09/13/2012WO2012122125A2 Compositions and methods targeting force generation in kinesin
09/13/2012WO2012122088A1 Apparatus and method for processing a sample
09/13/2012WO2012121953A1 Methods and pharmaceutical compositions for treating lymphoid malignancy
09/13/2012WO2012121678A1 METHOD OF USING CD1d OVER-EXPRESSION IN HUMAN DENDRITIC CELLS TO ENHANCE CD8+ T CELL-BASED AND INVARIANT NATURAL KILLER T CELL- BASED ANTITUMOR IMMUNITY
09/13/2012WO2012121419A1 Composition for synthesizing protein with reduced lipopolysaccharide contamination, method for producing protein using said composition
09/13/2012WO2012121395A1 Cholesterol-dependent cytolysin variant and use thereof in dds
09/13/2012WO2012121392A1 Azophosphorus compound and azole compound library and method for producing same
09/13/2012WO2012121324A1 Method for selecting effective group of cancer treatments combining use of three agents of taxane-based anticancer agent, platinum complex-based anticancer agent, and pyrimidine fluoride-based anticancer agent
09/13/2012WO2012121261A1 Method for screening for compound capable of enhancing or inhibiting oatp1b1 transport activity, and method for determining expression level of oatp1b1
09/13/2012WO2012121225A1 Nucleic acid detection method, and device and kit for use in same
09/13/2012WO2012121178A1 Tumor angiogenesis inhibitor
09/13/2012WO2012121150A1 Hydrogen peroxide resistance-imparting gene and method for using same
09/13/2012WO2012121144A1 Method of analyzing l-tryptophan in biological samples, and kit used therein
09/13/2012WO2012121093A1 Complex disease resistant monocot having optimized agronomic characteristics
09/13/2012WO2012121071A1 ADENOVIRUS VECTOR IN WHICH VA-RNAs ARE NOT EXPRESSED
09/13/2012WO2012121041A1 Method for producing sialic-acid-containing sugar chain
09/13/2012WO2012121029A1 Method for accumulating protein in plant cells
09/13/2012WO2012120500A2 Low fucose cell lines and uses thereof
09/13/2012WO2012120375A1 Engineering thraustochytrid microorganisms
09/13/2012WO2012120269A1 Molecular targets for healing or treating wounds
09/13/2012WO2012120044A1 Tfeb variants and uses thereof
09/13/2012WO2012119949A1 Means and methods for the treatment of neurodegenerative disorders
09/13/2012WO2012119938A2 Use of aptamers in therapy and/or diagnosis of autoimmune diseases
09/13/2012WO2012119484A1 Plasmid and method for using plasmid to increase yield of streptomyces antibiotic
09/13/2012WO2012119203A1 Gene expression and eradication system in helicobacter pylori
09/13/2012WO2012097304A3 Treponema pallidum triplet antigen
09/13/2012WO2012087958A3 Yeast promoters
09/13/2012WO2012082821A3 Melanoma treatments
09/13/2012WO2012073047A3 Compositions and methods
09/13/2012WO2012064162A3 Membrane protein expression vector comprising a fusion partner consisting of the envelope protein p9 of cystovirus phi 12, and a membrane protein production method using the same
09/13/2012WO2012061910A3 Main immunoprotective domains and epitopes of nucleoside hydrolase from leishmania (l) donovani for use in vaccination, immunotherapy and diagnosis
09/13/2012WO2012048817A3 Recombinant modified vaccinia virus ankara (mva) influenza vaccine
09/13/2012WO2012045088A3 Combinatorial design of highly efficient heterologous pathways
09/13/2012WO2011140086A3 Serum albumin binding molecules
09/13/2012WO2006132446A9 Method of manufacturing probe-immobilized carrier
09/13/2012US20120233727 Cloning of cytochrome p450 genes from nicotiana
09/13/2012US20120233726 Novel bacillus thuringiensis gene with lepidopteran activity
09/13/2012US20120233725 Method of Using Carbon Nanotubes to Affect Seed Germination and Plant Growth
09/13/2012US20120233724 Generation of plants with altered protein, fiber, or oil content
09/13/2012US20120233723 Herbicide-resistant rice plants, polynucleotides encoding herbicide resistant acetohydroxyacid synthase large subunit proteins, and methods of use
09/13/2012US20120233721 Cotton Cultivar L-1851
09/13/2012US20120233720 Tomato hybrid ex15567631 and parent lines thereof
09/13/2012US20120233719 Tomato hybrid ex15567101 and parent lines thereof
09/13/2012US20120233718 Use of pon gene cluster in preparing medicament for treating atherosclerosis
09/13/2012US20120233716 Novel fatty acid elongase and uses thereof
09/13/2012US20120233715 Human artificial chromosome vector
09/13/2012US20120232260 Amphiphilic nucleotide cochleate compositions and methods of using the same
09/13/2012US20120232259 Compositions and methods for modulating lymphocyte activity
09/13/2012US20120232133 Delivery of proteins using adeno-associated virus (aav) vectors
09/13/2012US20120232131 Gene expression and pain
09/13/2012US20120232130 Methods for inhibiting starvation of a cell
09/13/2012US20120232127 Regulation of neurotransmitter release through anion channels
09/13/2012US20120232125 Modulation of diacylglycerol acyltransferase 1 expression
09/13/2012US20120232012 Compositions having antiangiogenic activity and uses thereof
09/13/2012US20120231964 Method for selecting nucleic acids that bond with high-affinity to a target
09/13/2012US20120231546 NOVEL ACETYL CoA CARBOXYLASES
09/13/2012US20120231545 Method for modifying bovine embryo stem cells and method for purifying proteins produced by modified bovine embryo stem cells
09/13/2012US20120231539 Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
09/13/2012US20120231537 Highly Pure Plasmid DNA Preparations
09/13/2012US20120231536 Chimeral internal ribosomal entry site sequence and uses thereof
09/13/2012US20120231526 Method for the Purification of Alphavirus Replicon Particles
09/13/2012US20120231525 Multivalent phage display systems and methods
09/13/2012US20120231524 Chimeric adenoviruses for use in cancer treatment
09/13/2012US20120231523 Recombinant factor x with no glycosylation and method for preparing the same
09/13/2012US20120231520 Novel fusion proteins and method of expression thereof
09/13/2012US20120231515 Butanol dehydrogenase enzyme from the bacterium achromobacter xylosoxidans
09/13/2012US20120231512 Preparation of alpha-ketopimelic acid
09/13/2012US20120231507 Novel cellulases with high activities
09/13/2012US20120231503 Gene Expression Technique
09/13/2012US20120231501 Methods For Increasing Homologous Recombination Of A Nucleic Acid Sequence
09/13/2012US20120231495 Production of non-yeast sterols by yeast
09/13/2012US20120231490 Method Of Differentiation From Stem Cells To Hepatocytes
09/13/2012US20120231474 Constructs that allow for detection and quantitation of membrane proteins
09/13/2012US20120231452 Assay for methylation in the gst-pi gene
09/13/2012US20120231449 Products and methods for enhanced transgene expression and processing
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231030 Multi-epitopic vaccine
09/13/2012US20120231028 Polyvalent vaccine
09/13/2012US20120231021 Antibodies specifically binding to the epidermal growth factor receptor
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120231005 Ax1 and ax189 psck9 antagonists and variants
09/13/2012US20120231003 Ox2 Receptor Homologs
09/13/2012US20120230995 Polyspecific binding molecules and uses thereof
09/13/2012US20120230992 Vegf-related protein
09/13/2012US20120230990 Humanized antibodies against human il-22ra
09/13/2012US20120230985 Humanized anti-factor d antibodies and uses thereof
09/13/2012US20120230980 OPTIMIZED Fc VARIANTS AND METHODS FOR THEIR GENERATION
09/13/2012US20120230979 NOGO Receptor Binding Protein
09/13/2012US20120230975 Fusion proteins
1 ... 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 ... 4023